Information Provided By:
Fly News Breaks for May 31, 2018
EXAS
May 31, 2018 | 07:23 EDT
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $68 from $60 as the American Cancer Society now recommends colorectal cancer screening to begin at age 45 instead of 50. The age difference adds roughly 20M eligible Americans to be screened and comes at a time when the company increased its salesforce and is positioned for robust growth, said Davis, who reiterated his Buy rating on Exact Sciences shares.
News For EXAS From the Last 2 Days
There are no results for your query EXAS